Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
RHO5 RHO RHO6 NOVB Recreation Conglomerates Large Blend Exotic 
United States  USA  |  Macroaxis Daily Picks


Processing
Collecting data for NOVB

Novo quote and profile

 
 Companies |  Insiders  | Dashboard  
     
133.0
  
STOCK
(1.00)  Macroaxis: -0.75 Down   0.75%  
Year To Date
74.22131
Trading Day 
133134
May 19 2013 

Diversification Suggestion

Use Novo to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier
Analyze Novo Nordisk A-S Trend or Check current 30 days Novo correlation with market (DAX)
1 Month Beta 0.25  
Highest Price:  
Lowest Price:  
136.85  
126.8  
May 15 2013 
April 19 2013 
As returns on market increase, Novo returns are expected to increase less than the market. However during bear market, the loss on holding Novo will be expected to be smaller as well.
Novo Nordisk A-S Small BetaNovo Nordisk A-S Beta Legend
NOVB Germany XETRA #DK0060102614DE
Novo Nordisk A-S
Healthcare
Biotechnology
http://www.novonordisk.com
Contact Number: 45 44 44 88 88
Currency: EUR - Euro
Traded on XETRA Stock Exchange
    
Current Valuation66 B
Shares Outstanding542.58 M
Revenue13.54 B
Gross Profit40.64 B
 Germany DAX   0.34 % Macroaxis: 0.34 Moved Up  
 
 thisRed NOVB NOVB.DE agains markets  0.75 % Macroaxis: 0.75 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Novo Leadership

Lars S CEO and President and Member of the Sr. Management Board
Jesper MSc CFO, Executive VP, Member of the Sr. Management Board, Chairman of Novo Nordisk Engineering A/S and Chairman of Novo Nordisk IT A/S
K Schultz COO, Executive VP and Member of the Sr. Management Board

Novo Price and Market Media

The median price of Novo for the period between Fri, Apr 19, 2013 and Sun, May 19, 2013 is 132.55 with a coefficient of variation of 1.8. The daily time series for the period is distributed with a sample standard deviation of 2.38, arithmetic mean of 131.95, and mean deviation of 1.65. The Stock did not receive any noticable media coverage during the period.
Novo         Market
Price Growth (%)
 

Novo Summary

Novo Nordisk A-S [NOVB] is traded on XETRA Stock Exchange in Germany. It is located in Bagsvaerd, and employs 34,286 people. The company currently falls under 'Large-Cap' category with current market capitalization of 71.35 B. Novo Nordisk A-S operates under Healthcare sector and is part of Biotechnology industry. This company has 542.58 M outstanding shares.
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical solutions primarily in Denmark. more
Past Market
Over 30
Days
13
Out Of
100
 
Chance of
Less
Than
%
 
Follow Novo with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Novo to your reader
 

Novo Research Report

Novo vs. Roche

Correlation analysis and fundamentals comparison between Novo Nordisk A-S and Roche Holding AG

Novo Executives

K Schultz COO, Executive VP and Member of the Sr. Management Board

Novo Management

Mads Thomsen Chief Science Officer, Executive VP and Member of the Sr. Management Board
Lise Kingo Chief of Staffs, Executive VP of Corporate Relations and Member of the Sr. Management Board

Novo Fundamentals

Profit Margin vs Z Score
Book Value Per Share vs Earnings Per Share
Profit Margin vs Number of Employees
One Year Low vs Earnings Per Share

Novo vs Competition

Novo vs. Roche Holding AG
Novo vs. Roche Holding AG
Novo vs. Roche Holding AG
Novo vs. Novo Nordisk A-S
Novo vs. Amgen Inc
Novo vs. Gilead Sciences Inc
Novo vs. Biogen Idec Inc
Novo vs. Alexion Pharmaceuticals Inc
Novo vs. Actelion Ltd

Novo May 19 2013 Opportunity Range

Downside Deviation1.02
Information Ratio(0.36)
Maximum Drawdown4.15
Value At Risk(0.75)
Potential Upside1.9

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium